Michael A. Boxer
Michael A. Boxer publishes mostly in Genetics, Hematology and Pathology and Forensic Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #753,216 of 7,710,434 ranked researchers
- Rank in United States
- #252,854 of 1,627,098
- Works
- 59
- Citations
- 1.9k
- Citations per work
- 32.2
What does Michael A. Boxer research?
Michael A. Boxer's work is mostly in Medicine (65%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3965.3%
- Medicine3965.3%
- Everything else1829.8%
- Life Sciences34.9%
- 1Genetics25% of their works
- 2Hematology18% of their works
- 3Pathology and Forensic Medicine13% of their works
- 4Surgery5% of their works
- 5Immunology5% of their works
- 6Radiology, Nuclear Medicine and Imaging5% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Platelet Disorders and Treatments
- Chronic Myeloid Leukemia Treatments
- Immunodeficiency and Autoimmune Disorders
- Monoclonal and Polyclonal Antibodies Research
- Autoimmune Bullous Skin Diseases
Which keywords describe Michael A. Boxer's research?
The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, JAK2 Mutation, Myelofibrosis and BCR-ABL.
- Autoantibodies
- Primary Immunodeficiency
- Fc Receptors
- Platelets
- BCR-ABL
- JAK2 Mutation
- Classification
- Chronic Lymphocytic Leukemia
- Rituximab
- Genomic Aberrations
- Lymphoma
- Myelofibrosis
- Imatinib
- Thrombosis
- Genetic Mutations
- Therapeutic Antibodies
- Pemphigoid
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Rituximab493 topics
- Chronic Lymphocytic Leukemia291 topic
- Genomic Aberrations291 topic
- Classification141 topic
- Lymphoma141 topic
- JAK2 Mutation111 topic
- Myelofibrosis111 topic
- BCR-ABL91 topic
- Imatinib91 topic
- Platelets91 topic
- Thrombosis91 topic
- Fc Receptors81 topic
- Genetic Mutations81 topic
- Primary Immunodeficiency81 topic
- Therapeutic Antibodies81 topic
- Autoantibodies61 topic
- Pemphigoid61 topic
Where does Michael A. Boxer work?
Michael A. Boxer's main affiliation in the publication record is Arizona Oncology, United States.
How many publications and citations does Michael A. Boxer have?
OpenAlex counts 59 works and 1,900 citations for Michael A. Boxer, an h-index of 18, ranking #753,216 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael A. Boxer. Posts are plain text and can be reported.